Impact of a simulation-based ergonomics training curriculum on work-related musculoskeletal injury risk in colonoscopy - 06/11/20
Abstract |
Background and Aims |
Endoscopists are at risk of developing musculoskeletal injuries (MSIs), and few receive training on ergonomics. The aim of this study was to determine the impact of a simulation-based ergonomics training curriculum (ETC) on work-related MSI risk during clinical colonoscopy.
Methods |
Novice endoscopists underwent a simulation-based ETC and were compared with an historical control group who received simulation-based training without ergonomics training. The ETC included a didactic lecture and video on ergonomics in colonoscopy, feedback from supervisors on ergonomics, and an ergonomics checklist to augment feedback and promote self-reflection. Participants were assessed using the rapid entire body assessment (REBA) and rapid upper limb assessment (RULA). The primary outcome was participants’ REBA scores during 2 clinical colonoscopies 4 to 6 weeks after training.
Results |
In clinical colonoscopy, the ETC group had superior REBA scores (clinical procedure 1: median score, 6 vs 11; P < .001; clinical procedure 2: median score, 6 vs 10; P < .001). In a simulated colonoscopy, the ETC group did not have significantly different REBA or RULA scores between baseline, immediately after training, and 4 to 6 weeks after (REBA: median scores of 5, 5, and 5, respectively; P > .05; RULA: median scores of 6, 6, and 6, respectively; P > .05). The control group had worsening REBA and RULA scores during the study timeline (REBA: median scores of 5 at baseline, 9 immediately after training, and 9 at 4-6 weeks after training; P < .001; RULA: median scores of 6, 7, and 7, respectively; P = .04) during simulated procedures.
Conclusions |
A simulation-based ETC is associated with reduced risk of MSI during endoscopy. Although the REBA score was improved, the intervention group was still within the medium-risk range.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Abbreviations : ETC, MSI, REBA, RULA
Plan
| DISCLOSURE: The following authors disclosed financial relationships: R. Khan: Research support from AbbVie (USA), Ferring Canada (Canada), and Pendopharm. S. C. Grover: Research support from AbbVie (USA), Ferring Canada (Canada), and Janssen; speaker and consultant for Takeda; equity in Volo Healthcare. All other authors disclosed no financial relationships. Research support for this study was provided by a Canadian Association of Gastroenterology (Canada) Education Research Grant and an Intramural Award in Education from the Division of Gastroenterology, University of Toronto. |
|
| If you would like to chat with an author of this article, you may contact Dr Grover at samir.grover@utoronto.ca. |
Vol 92 - N° 5
P. 1070 - novembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
